+ All Categories
Home > Documents > UGIB CASE STUDY

UGIB CASE STUDY

Date post: 24-Nov-2014
Category:
Upload: venus-glaze-verzola
View: 11 times
Download: 2 times
Share this document with a friend
Popular Tags:
38
I. INTRODUCTION UPPER GASTROINTESTINAL BLEEDING Originates in the GI tract from the mouth to the ligament of Treitz where the duodenum, the first part of the small intestine, ends. Bleeding from the esophagus may occur from esophageal varices, dilation of the veins in the esophagus. One of the symptoms of upper GI bleeding is vomiting of blood (hematemesis).If the blood travels through the GI tract, the stool may appear tarry and black (melena) because of digested blood, though the stool can still be stained with red blood (hematochezia). About 75% of patients presenting to the emergency room with GI bleeding have an upper source. The diagnosis is easier when the patient has hematemesis. In the absence of hematemesis, 40% to 50% of patients in the emergency room with GI bleeding have an upper source. Determining whether a patient truly has an upper GI bleed versus lower gastrointestinal bleeding is difficult. Mortality is about 11% in patients admitted with an UGIB.2 It is as high as 33% in patients who develop bleeding whilst in hospital. A score of less than 3 using the Rockall system above is associated with an excellent prognosis, whereas a score of 8 or above is associated with high mortality.3 Most deaths occur in elderly patients with co- morbidity. Mortality is reported to be lower in specialist units possibly because of adherence to protocols rather than because of technical advances.2 The prognosis in liver disease relates significantly to the severity of the liver disease rather than to the magnitude of the haemorrhage Upper gastrointestinal bleeding is commonly caused by bleeding varices (varicose veins) in the esophagus, peptic ulcers or a
Transcript
Page 1: UGIB CASE STUDY

I. INTRODUCTION

UPPER GASTROINTESTINAL BLEEDING

Originates in the GI tract from the mouth to the ligament of Treitz where the duodenum, the first part of the small intestine, ends. Bleeding from the esophagus may occur from esophageal varices, dilation of the veins in the esophagus. One of the symptoms of upper GI bleeding is vomiting of blood (hematemesis).If the blood travelsthrough the GI tract, the stool may appear tarry and black (melena) because of digested blood, though the stool can still be stained with red blood (hematochezia). About 75% of patients presenting to the emergency room with GI bleeding have an upper source. The diagnosis is easier when the patient has hematemesis. In the absence of hematemesis, 40% to 50% of patients in the emergency room with GI bleeding have an upper source. Determining whether a patient truly has an upper GI bleed versus lower gastrointestinal bleeding is difficult. Mortality is about 11% in patients admitted with an UGIB.2 It is as high as 33% in patients who develop bleeding whilst in hospital. A score of less than 3 using the Rockall system above is associated with an excellent prognosis, whereas a score of 8 or above is associated with high mortality.3 Most deaths occur in elderly patients with co-morbidity. Mortality is reported to be lower in specialist units possibly because of adherence to protocols rather than because of technical advances.2 The prognosis in liver disease relates significantly to the severity of the liver disease rather than to the magnitude of the haemorrhage

Upper gastrointestinal bleeding is commonly caused by bleeding varices (varicose veins) in the esophagus, peptic ulcers or a Mallory- Weiss tear at the esophageal gastric junction from severe retching .Otherwise, bleeding over time results in anemia, characterized by lower than normal blood hemoglobin and hematocrit with symptoms like weakness, fatigue, and fainting.

The most important step to evaluate upper GI bleeding is upper endoscopy. During this procedure, performed by a gastroenterologist, a tube with a camera (endoscope) is passed into the mouth and down the esophagus. The gastroenterologist can proceed to the stomach and duodenum and localize the source of the bleeding, if possible. Other examination to determine UGIB are Vital signs, in order to determine the severity of bleeding and the timing of intervention. Abdominal and rectal examination, in order to determine possible causes of hemorrhage. Assessment for portal hypertension and stigmata of chronic liver disease in order to determine if the bleeding is from a variceal source.

Page 2: UGIB CASE STUDY

Laboratory findings include anemia, coagulopathy, and an elevated BUN-to-creatinine ratio.

Emergency treatment for upper GI bleeds includes aggressive replacement of volume with intravenous solutions, and blood products if required. As patients with esophageal varices typically have coagulopathy, plasma products may have to be administered. Vital signs are continuously monitored.Early endoscopy is recommended, both as a diagnostic and therapeutic approach, as endoscopic treatment can be performed through the endoscope. Therapy depends on the type of lesion identified, and can include:injection of adrenaline or other sclerotherapy, electrocautery, endoscopic clipping, or banding of varices. Stigmata of high risk include active bleeding, oozing, visible vessels and red spots. Clots that are present on the bleeding lesion are usually removed in order to determine the underlying pathology, and to determine the risk for rebleeding. Pharmacotherapy includes the following: Proton pump inhibitors (PPIs), which reduce gastric acid production and accelerate healing of certain gastric, duodenal and esophageal sources of hemorrhage. These can be administered orally or intravenously as an infusion depending on the risk of rebleeding. Octreotide is a somatostatin analog believed to shunt blood away from the splanchnic circulation. It has found to be a useful adjunct in management of both variceal and non-variceal upper GI hemorrhage. It is the somatostatin analog most commonly used in North America. Terlipressin is a vasopressin analog most commonly used in Europe for variceal upper GI hemorrhage. Antibiotics are prescribed in upper GI bleeds associated with portal hypertension.

If Helicobacter pylori is identified as a contributant to the source of hemorrhage, then therapy with antibiotics and a PPI is suggested.

Page 3: UGIB CASE STUDY

II. OBJECTIVES

General objectives:

This case study focuses on the advancement of my skills in managing and administering the extensive range of my intervention to my client with Upper Gastrointestinal Bleeding (UGIB). This study will further help me to expand my knowledge about the said disease.

Specific objectives:

1. To established good rapport to the client and to get the physical assessment.

2. To define what is Upper Gastrointestinal Bleeding (UGIB).

3. To trace the pathophysiology of UGIB.

4. To enumerate the different signs and systems of UGIB.

5. To formulate and apply necessary nursing care plans utilizing the nursing process.

Page 4: UGIB CASE STUDY

III. DEMOGRAPHIC DATA

Name: Mrs. E.M.C

Age: 47 y/o

Gender: Female Spouse: Armando A. Cacho

Status: Married Chief Complaint: Change in Sensoruim

Nationality: Filipino Date admitted: November 11, 2010

Religion: INC Time admitted: 10:30 am

Blood type: O+

Address: BKL3 LOT 10 PH Dela Costa Homes 3, SJDM, Bulacan

Final Diagnosis: Upper Gastrointestinal Bleeding (UGIB)

CLINICAL ABSTRACT

This is the case of EMC 47 y/o female from BKL3 LOT 10 PH Dela Costa Homes 3, SJDM, Bulacan. She was born on September 15, 1963. She is married for 22 years now and has 6 children. Mrs. EMC is a non smoker and non alcoholic beverages drinker.

Mrs. EMC was admitted to East Avenue Medical Center on November 11, 2010, 10:30 in the morning. She was admitted due to dizziness, loss of consciousness and change of sensorium.

HISTORY OF PRESENT ILLNESS

One week prior to admission the patient had experienced dizziness and vomiting of previous ingested food but still conscious and able to communicate. Three days prior to admission Mrs. EMC had experienced anorexia and abdominal pain. Few hours prior to admission Mrs. EMC still in the previous symptoms, and rushed to the ER of EAMC.

November 11, 2010 the physician ordered CBG monitoring, serum glucose control which revealed type 2 DM, start of empiric antibiotic which revealed complicated UTI and had her laboratory examinations like blood chemistry, hematology test and urinalysis. On the same day she undergone upper endoscopy with biopsy which revealed gastric ulcer. On the 13 th day of Nov. she had her cross matching which revealed her blood type which is type ”O” positive. Nov. 21 she had undergone to IJ catheter insertion for dialysis.

PAST MEDICAL HISTORY

Page 5: UGIB CASE STUDY

According to the patient she has a hypertension, DM and BA (last attack 20 vq). She is negative to PTB and thyroid disease. She had no maintenance on her HPN, for her DM she took Metformin.

FAMILY MEDICAL HISTORY

(+) Hypertension (-) PTB

(+) DM (-) Thyroid disease

(+) BA

LIFE STYLE

A. Personal Habit

The patient does not smoke nor drinks alcoholic beverages.

B. Diet

She eats three times a day and drinks 6-8 glass of water per day and sometimes she also drinks soft drinks. The patient’s usual diet includes rice, meats like pork, beef, chicken and fish. According to the patient, she seldom eats vegetables. She is fond of eating sweets and lechon. She also drinks coffee often (4x a day).

C. Recreational Activity

She watch television during her free time after she had finish the household choirs.

D. Sleep and Rest

She said that she spends 6 hours of sleep every night and she takes naps if she had free time. She usually sleeps at 11:00 in the evening and wakes up at 5:00 in the morning she said that it is continuous and she feels refreshed after waking up.

E. Activities of Daily Living

The patient works everyday in their house and sometimes she accepts laundry. Every weekend she allotted time to rest and to have bonding with her family. She said she do the household choirs before she starts washing her accepted laundry from her neighbors.

Page 6: UGIB CASE STUDY

PATIENT’S SOCIAL HISTORY

A. Family Relationship and Friends

The patient’s family is nuclear type together with her husband Armando A. Cacho, her six children. According to her she has a good relationship with each member of her family and also with her friends. She allotted time to bond with her family.

B. Occupational History

The patient is self employed.

C. Economic History

According to the patient her husband is a constructor and an OFW before. Her husband is the one who brings income in their family. According to her husband work is enough to support their children’s need. Her accepted laundry from their neighbors helps them in their needs and it is an additional income to them and it satisfies their needs.

IV. PHYSICAL ASSESSMENT

Page 7: UGIB CASE STUDY

Actual Findings Normal Findings Interpretation Head

Skull

Scalp

Hair

Face

Eyes

Eyebrows

Eyelashes

Eyelids

-Normocephalic-No lumps

-No nits, lice and dandruff-no baldness

-Straight, Black with white hair, oily hair

-Symmetrical with movement-Expressions appropriate to situations

-Symmetrical-No cloudiness-No Lacrimation

-Symmetrical

-Equally distributed-Curved slightly outward

-Skin intact-No discharge-No discoloration-Lids close symmetrically

-Normocephalic-Smooth-No lumps-Absence of modules or masses-No area of tenderness-Symmetrical with protrusions on the lateral part of parietal forehead and occipital bone.

-Whitish -No nits, lice and dandruff-no baldness

-Black or brown in color-Hair is evenly distributed-No area of baldness-Thick-Fine-Curly/kinky/straight-Dry/oily/shiny hair

-Symmetrical with movement-Expressions appropriate to situations

-Symmetrical-No protrusions-Dear or no Cloudiness-No excessive Lacrimation

-Moves symmetrically-Hair evenly distributed-Skin Intact

-Equally distributed-Curved slightly outward

-Skin intact-No discharge-No discoloration-Lids close symmetrically

-Normal

-Normal

-Normal

-Normal

-Normal

-Normal

-Normal

-Normal

Page 8: UGIB CASE STUDY

Lid margins

Lower palpebral conjunctiva

Sclera

Iris

Pupils

Eye Movement

Field of vision*Visual acuity

Ear

-approximately 15-20 involuntary blinks per minute; bilateral blinking

-No secretions-No erythema-No redness

-Pink, shiny, with visible blood vessels-No discharges

-White in color-Clear- No redness

-Flat-Brown-Round-Transparent/Shiny

-PERRLA

-Moves in unison-coordinated

-Same as the color of the face-No swelling-Shell shape

-approximately 15-20 involuntary blinks per minute; bilateral blinking

-No scaling-No secretions-No erythema-No redness

-Pink, shiny, with visible blood vessels-No discharges

-White/yellowish in black Americans-Clear, No cloudiness-No redness

-Flat-Brown-Even coloration-Symmetrical-Round-Transparent/Shiny

-PERRLA(Pupils Equally Round, Reactive to Light & Accommodation

-Moves in unison-coordinated

-Good peripheral vision-20/20 in both eyes

-Parallel with outer canthus of the eyes-Same as the color of the face-No swelling

-Normal

-Normal

-Normal

-Normal

-Normal

-Normal

-Normal

-Normal

Page 9: UGIB CASE STUDY

Ear Canal

Hearing acuity

Nose

Lips

Gums

Teeth

Tongue

Frenulum

- Waxy cerumen-Presence of cilia

-With good hearing acuity in both ears

-No lesions-Presence of cilia

-Darker lips-Ability to purse lips

-Pink, moist-No swelling-No tenderness-No discharges

-white

-Pink, even, rough dorsal surface and moist

-No tenderness-Shell shape-Firm cartilage

-Yellowish-Dry/waxy cerumen-Presence of cilia-No foreign body

-With good hearing acuity in both ears

-Symmetric and straight-No discharge or flaring-Uniform color-No tenderness-No lesions-Presence of cilia

-Uniform pink color(darker, e.g,Bluish hue, in Mediterranean groups and dark-skinned clients)-Soft, moist, smooth texture-Symmetry of contour-Ability to purse lips-No tenderness

-Pink, moist-No swelling-No tenderness-No discharges-No retraction(lower and upper)

-32 in number-White-Upper teeth over-rides lower teeth

-Pink, even, rough dorsal surface and moist

-Normal

-Normal

-Normal

-Decrease of oxygen supply

-Normal

-Normal

-Normal

Page 10: UGIB CASE STUDY

Soft Palate

Hard Palate

Uvula

Tonsils

Neck

Upper Extremities Skin

-Midline-pinkish-With visible veins

-Pink, moist, no swelling/No tenderness

-Bony, Light pink in color, moist

-Midline moves when the client says “Aah”

-Pinkish-No discharge-No inflammation

-Same as the skin color-No lymphs, No mass

-No abrasions or other lesions-When pinched, skin springs back to previous state- with edema

-Midline-pinkish-With visible veins

-Pink, moist, no swelling/No tenderness

-Bony, Light pink in color, moist

-Pink, moist-Midline moves when the client says “Aah”

-Pinkish-No discharge-No inflammation

-Erect & midline-Same as the skin color-No tenderness-No lymphs, No mass-Symmetrical-Muscles equal in size; head centered-Coordinated, smooth movements with no discomfort

-Varies from light to deep brown; from ruddy pink to light pink; from yellow overtones to olive-No edema-No abrasions or other lesions-Freckles, some birthmarks, some flat and raised nevi-When pinched, skin springs

-Normal

-Normal

-Normal

-Normal

-Normal

-Normal

-accumulation of excess fluid

Page 11: UGIB CASE STUDY

Nails

Chest and back Posterior

Thorax

Anterior Thorax

Abdomen

-Convex curvature-white

-No tenderness-No masses

-Full expansion-Tachypnea

-Unblemished skin-Uniform color

back to previous state

-Convex curvature-Smooth texture-Highly vascular and pink in light-skinned clients; dark-skinned clients may have brown or black pigmentation in longitudinal streaks-Intact epidermis-Prompt return of pink or usual color(generally less than 4 seconds)

-Chest symmetric-Skin Intact; uniform temperature-Chest wall intact-No tenderness-No masses-Full and symmetric chest expansion-Vesicular and bronchovesicular sounds

-Quiet, rhythmic, and effortless respirations-Full symmetric excursion-Bronchial and tubular breath sounds in the trachea-Vesicular and bronchovesicular breath sounds

-Unblemished skin-Uniform color-Silver-white striae or surgical scars-Flat, rounded(convex),or scaphoid (concave)- Symmetric movements caused

-Decrease O2 supply

-Normal

-Difficulty of breathing

-Normal

Page 12: UGIB CASE STUDY

Lower extremities

Skin

Nails

Motor functions:

-Brown in color- with edema- No abrasions or other lesions- with edema

- Concave curvature -Brown pigmentation in longitudinal streaks

- Repeatedly and rhythmically touches the nose- Rapidly touches each finger to thumb with each hand- Can readily determine the position of fingers and toes

by respiration- Audible bowel sounds - No tenderness- Relaxed abdomen with smooth, consistent tension

- Varies from light to deep brown; from ruddy pink to light pink; from yellow overtones to olive- No edema- No abrasions or other lesions- Freckles, some birthmarks, some flat and raised nevi- when pinched, skin springs back to previous state

- Concave curvature - Smooth texture- highly vascular and pink in light-skinned clients; dark-skinned clients may have brown or black pigmentation in longitudinal streaks- Intact epidermis- Prompt return of pink or usual color (generally less than 4 secs.)

- Has upright posture and steady gait with opposing arm swing; walks unaided, maintaining balance- May sway slightly but is able to maintain upright posture and foot stance.- Maintain stance for at least 5 secs- maintains heel-toe walking along straight line- Repeatedly and rhythmically

- accumulation of excess fluid

-Normal

-Normal

Page 13: UGIB CASE STUDY

touches the nose- Rapidly touches each finger to thumb with each hand- Can readily determine the position of fingers and toes

GORDONDS

Before hospitalization

During hospitalization

Interpretation Analysis

a. activity-exercise pattern- hobbies

Elimination pattern

According to her she does the household choirs and at the same time it is her way of exercising and she can perform different activities.

Prior to hospitalization she defecates every day. She urinates normal amount and normal color. urinates

During her hospitalization she is in complete bed rest.

For the period of hospitalization her defecation does not vary but her urine

output decreases.

She was not able to perform the activities because of the disease process.

The patient’s elimination pattern changed during hospitalization because she is under medication.

Exercise is very important to our body because it promotes good health and helps us build and maintain healthy muscles, bones, and joints and it reduces depression and anxiety.

Good elimination pattern reduces the risk of having cancer. It helps us to detoxify waste in our body to free ourselves from complications

Page 14: UGIB CASE STUDY

Sleep and rest pattern

Cognitive-perceptual pattern

Self –perception and self-concept pattern

Role-relationship pattern

Before she sleeps 6 hours every day

The patient is a 2nd year college undergraduate. She is literate.

Prior to hospitalization she is a happy person and positive thinker.

The patient’s family is nuclear type. They are 8 in the family. They have 6 children and she allotted time for her family to bond. She is sociable to everyone.

Throughout her hospitalization sleeps 12 hours and can take naps.

Same

During her hospitalization she is still a positive thinker.

Throughout her hospitalization her family is with her side at all times to support her.

Due to confinement the patient has no problem with her sleep.

Due to confinement the patient has no problem with understanding

Even she is in the hospital herself perception does not change. She stayed the same as she was before.

Due to her hospitalization the family becomes closer to one another and become stronger.

Enough and good sleep and rest pattern can reduce stress, helps us to think better.

Good education is important to overcome poverty.

Good self-perception and self-concept pattern helps us to overcome problems and trials.

Good relationship to each member of the family creates unity and compact relationship with each other. Good relationship with other people can gain trust, acceptance, support, and someone to Call On When You Need a Hand.

Page 15: UGIB CASE STUDY

Coping-stress tolerance pattern

Health perception

Sexuality- reproductive pattern

Values- belief pattern

Ever time she encounters difficulties she asks guidance and help from God.

According to her health is very important because it is wealth.

Before hospitalization she menstruates regularly.

She is an INC. They go to church every Thursday and Sunday.

During her hospitalization she just prays every time she’s in pain.

During her hospitalization she still believes that health is wealth.

Same

During her hospitalization her husband and her always prays for her health.

Her coping stress is the same as what she is doing before.

Her health perception is the same as what she believes before.

Her reproductive system works properly.

Her values- belief pattern does not change and her faith to God become stronger.

Having a good coping to stress can overcome stressors and depressions.

Good health perception can maintain health, the body can function properly and it acts as personal strength.

Good sexuality- reproductive can easily determine the fertilization and can prevent cancers in reproductive system.

Strong values-beliefs help us to overcome difficulties and trials.

V. ANATOMY AND PHYSIOLOGY

UPPER GI

Page 16: UGIB CASE STUDY

The upper GI tract consists of the mouth, pharynx, esophagus, and stomach. This is where ingestion and the first phase of digestion occur.

MOUTH

The mouth includes the tongue, teeth, and buccal mucosa or mucous membranes containing the ends of the salivary glands, continuous with the soft palate, floor of the mouth and under side of the tongue. Chewing (mastication) is the mechanical process by which food, constantly repositioned by muscular action of the tongue and cheeks, is crushed and ground by the teeth through the muscular action of the lower jaw (mandible) against the fixed resistance of the upper jaw (maxilla).

Saliva excreted in the oral cavity by three pairs of exocrine glands (parotid, submandibular, and sublingual) is mixed with chewed food to form a bolus, or ball-shaped mass. There are two types of saliva: a thin watery secretion that wets the food and a thick mucous secretion that lubricates and causes the food particles to stick together to form the bolus.

Digestive enzymes in saliva begin the chemical breakdown of food, primarily starches at this point, almost immediately.

PHARYNX

Page 17: UGIB CASE STUDY

The pharynx is contained in the neck and throat and functions as part of both the digestive system and the respiratory system. The human pharynx is divided into three sections: the nasopharynx behind the nasal cavity and above the soft palate;

The oropharynx behind the oral cavity and including the base of the tongue, the tonsils, and the uvula; the hypopharynx or laryngopharynx includes the junction with the esophagus and the larynx, where respiratory and digestive pathways diverge. The swallowing reflex is initiated by touch receptors in the pharynx as the bolus of chewed food is pushed to the back of the mouth.

Swallowing automatically closes down the respiratory or breathing pathway as an anti-choking reflex. Failure or confusion of reflexes at this point can result in aspiration of solid or liquid food into the trachea and lungs.

ESOPHAGUS

The esophagus is the hollow muscular tube through which food passes from the pharynx to the stomach. It is also lined with mucous membrane continuous with the mucosa of the mouth and into which open the esophageal glands.

The esophagus is surrounded by relatively deep muscles that move the swallowed bolus of masticated food through peristaltic action, piercing the thoracic diaphragm to reach the stomach.

Page 18: UGIB CASE STUDY

STOMACH

The stomach is a hollow muscular organ, located below the diaphragm and above the small intestine that receives and holds masticated food to begin the next phase of digestion. Two smooth muscle valves, the esophageal sphincter above and the pyloric sphincter below, keep stomach contentscontained.

The stomach is surrounded by stimulant (parasympathetic) and inhibitor (orthosympathetic) nerve plexuses which regulate both secretory and muscular activity during digestion. With a volume of as little as 50 mL when empty, the adult human stomach may comfortably contain about a liter of food after a meal, or uncomfortably as much as 4 liters of liquid.

DUODENUM

Page 19: UGIB CASE STUDY

The duodenum precedes the jejunum and ileum and is the shortest part of the small intestine, where most

chemical digestion takes place. The nameduodenum is from the Latin duodenum digitorum, or twelve

fingers' breadths.

In humans, the duodenum is a hollow jointed tube about 10–12 in long connecting the stomach to

the jejunum. It begins with the duodenal bulb and ends at the ligament of Treitz.

The duodenum is largely responsible for the breakdown of food in the small intestine, using

enzymes. Brunner's glands, which secrete mucus, are found in the duodenum. The duodenum wall is

composed of a very thin layer of cells that form the muscularis mucosae. The duodenum is almost entirely

retroperitoneal.

The duodenum also regulates the rate of emptying of the stomach via hormonal

pathways. Secretin and cholecystokinin are released from cells in the duodenal epithelium in response to

acidic and fatty stimuli present there when the pylorus opens and releases gastric chyme into the duodenum

for further digestion. These cause the liver and gall bladder to release bile, and the pancreas to release

bicarbonate and digestive enzymes such as trypsin,lipase and amylase into the duodenum as they are

needed.

VI. PATHOPHYSIOLOGY

Precipitating factors Contributing factors Predisposing factors

old NSAIDs use Stress

Diet: spicy foods and coffee

Page 20: UGIB CASE STUDY

-Generalized body weakness BP: 180/90 RR:25 PR:90

-Dizziness

VII. LABORATORY

URINALYSIS

Definition:

Elicit their effects on cyclooxegenase

Disruption of mucous barrier

Inflammatory effect on gastric mucusa Neutrophils – 86%

Ulcers burrows deep

Weakening and necrosis of arterial

Development of pseudo anuerysms

Weakened wall raptures leading

Peripheral vasoconstriction

Pale nail beds and conjuctivitis

UGIB

Page 21: UGIB CASE STUDY

 Is an array of tests performed on urine and one of the most common methods of medical diagnosis.

Indication:

It is used to detect the presence of UTI, Proteinuria,Glucosuria, Ketonuria, presence of urinary sediments which indicates renal pathology.

Nursing Responsibility:

Instruct the patient perform perineal care prior to the procedure Collect urine from the first voiding in the morning and examine within 30 mins. Label specimen properly Instruct patient to keep labia majora separated while urinating Instruct the patient to collect specimen by a midstream catch

Parameters ResultsColor Light yellowTransparency Slightly cloudyReaction 5.0Sp gravity 1,020Albumin + 2Glucose (-)RBC count 1-2WBC count 25-30Epithelial cells FewMucus threads 0 cc’lBacteria ModerateAmorphousUratesCasts none

Analysis and interpretation

Laboratory results revealed that there is presence of Albumin in the blood, this indicates that the glomerular cannot filter large molecules such as that of Albumin. It also revealed that there is infection as evidence by presence of bacteria and red cells in the urine.

Hematology

Definition

Is the branch of internal medicine, physiology, pathology, clinical laboratory work, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. The laboratory work that goes into the study of blood is

Page 22: UGIB CASE STUDY

frequently performed by a medical technologist. Hematologists physicians also very frequently do further study in oncology - the medical treatment of cancer.

Indication

This test determines the concentration of hemoglobin in whole blood.

Nursing responsibility:

Explain the procedure to the patient

Collect blood sample by extraction from the vein in arm using needle or finger prick Label the specimen properly.

Parameters Normal Values ResultsHemoglobin M- 130- 180 g/l

F – 120-160 g/l60

Hematocrit M- 0.42-0.52F- 0.37- 0.48

0.181

WBC count 4.3-10.8x 10/lSegments 0.45-.0.74 0.83Lymphocytes 0.16-0.45 0.15Eosinophils 0-0.07Monocyte 0.04-0.10 0.02Basophils 0-0.02Bands 0.02-0.04Platelets 130-400x 10 /l 239ESR M- 0.15 mm/hr

F- 0.20 mm/hr RDW= 14.7 Normal MCV= 85.2 Normal MCH-= 28.3 Normal

MCHC= 332 Normal

Interpretation:

This test showed that the hemoglobin is less than the normal value therefore it indicates a decrease of oxygen in the blood.

Blood chemistry

Definition

A blood test is a laboratory analysis performed on a blood sample that is usually extracted from

a vein in the arm using a needle, or via finger prick.

Page 23: UGIB CASE STUDY

Indication

Blood tests are used to determine physiological and biochemical states, such

as disease, mineral content, drug effectiveness, and organ function. They are also used in drug

tests. Although the term blood test is used, most routine tests (except for most haematology ) are

done on plasma or serum, instead of blood cells.

Nursing responsibility

Explain the procedure to the patient

Collect blood sample by extraction from the vein in arm using needle or finger prick.

Label specimen properly

Parameters Normal values ResultsGlucose 3.9-8 + mmol/lUric acid .16-.43Urea nitrogen 2.5-6.1 1.2Creatinine 53-115 umol 61Cholesterol 0-5.2 mmol/lTriglycerides .23-1.71 mmol/lHDL .91 mmol/lTotal bilirubin 0.17-1 umol/lDirect bilirubin .5 umol/lIndirect bilirubin 0-12.1umol/lTotal protein 61-82 g/lAlbumin 34-50 g/lGlobulin 25-35 g/lA/G ratio 1.5-2.5SGOT 15-37 u/lSGPT 30-65 u/lAlkyl phosphate 50-136 u/lNa 140-148 mmol/l 126K 3.6-5.2 mmol/l 3.9CHON Value control secsAPPT Value control secs24 hr urine ECC M- .78-1.155 ml/sec

F- 1.03-1.81 ml/sec24 hr urine CHON 28-41 mg/24hrGlycosylated Hgb Up to 66%

Page 24: UGIB CASE STUDY

Total Hgb

B/C 4.87

ECC 111

Interpretation

Sodium and potassium are normal which means there is still fluid and electrolyte balance.

IX. Discharge plan

Clients with Upper Gastrointestinal Bleeding are instructed to take the following

plan for discharge.

Page 25: UGIB CASE STUDY

M- Medications should be taken regularly as prescribed, on exact dosage, time,

& frequency, making sure that the purpose of medications is fully disclosed by

the health care provider.

Losartan 50 mg/tab 1tab OD

Hydrocortisol 50 mg/tab 1tab

FeSo4 + folic acid 1tab TID

CaCo3 1tab

NaHCo3 1tab TID

Kalium durule 1tab x 2 days

Nefidipine 30 mg/tab BID

E- Exercise should be promoted in a way by stretching hand and feet every

morning. Encourage the patient to keep active to adhere to exercise program and

to remain as self –sufficient as possible

- bed rest

T- Treatment after discharge is expected for patients and watcher with UGIB to

fully participate in continuous treatment.

H- Health teachings regarding the importance of proper hygiene and hand

washing, intake of adequate water and vitamins especially vitamin C-rich foods to

strengthen the immune response and increasing of oral fluid intake should be

conveyed. Avoid spicy foods, carbonated beverages and coffee.

O- OPD such as regular follow-up check-ups should be greatly encouraged to

clients with UGIB as ordered by physician to ensure the continuing management

and treatment.

D- Diet which is prescribed should be followed.

S- Pray for faster healing and don’t losses hope.

Page 26: UGIB CASE STUDY

Endoscopy: Risk assessment in upper gastrointestinal bleeding

Ernst J. Kuipers  About the author

Abstract

Endoscopy is the mainstay for diagnosis and therapy of upper gastrointestinal bleeding. Early

risk assessment is crucial for effective timing of endoscopy and determination of the need for

other measures to be taken—scoring systems should be used for this purpose. A new

prospective study suggests that the Blatchford score can identify patients who do not need

endoscopic intervention.

Acute upper gastrointestinal bleeding (UGIB) is the gastrointestinal tract condition most likely to result in a medical

emergency. The estimated incidence of acute UGIB is 50–150 per 100,000 population per year: 40–60% of these bleeds are

caused by a peptic ulcer, 10% are related to varices, 10% are attributable to erosive esophagitis and the remainder are

caused by a variety of conditions. Endoscopic treatment is the main therapy for patients with UGIB. However, risk

assessment is necessary to determine whether endoscopic treatment is required; a study by Pang et al. has now assessed the

predictive value of two risk assessment scoring systems.

Endoscopic treatment, either with clips or thermocoagulation with or without epinephrine injection, can stop the initial

bleed and reduce the risk of rebleeding considerably. This treatment improves outcome, as it can shorten the hospital stay,

decrease the need for a blood transfusion, further endoscopic or surgical intervention, and reduce mortality. After adequate

endoscopic therapy, the outcome for high-risk patients (such as those with a visible vessel) can be further improved by

profound acid suppressive therapy by means of a PPI given intravenously.

Early risk assessment is crucial in patients presenting with UGIB to ensure optimal timing of endoscopy, and to determine

whether other measures (such as hospital admission, blood transfusion and treatment in an intensive care unit) are

required. Several risk assessment scales have been developed over the past 15 years that are based on retrospective

analyses of cohorts of patients presenting with UGIB. Prospective cohort studies are required to assess the validity and

usefulness of these scoring systems. For that purpose, Pang and colleagues compared two frequently used risk assessment

scales—the Blatchford and pre-endoscopic Rockall scoring systems—for their ability to predict the need for endoscopic

therapy.3

Early risk assessment is crucial in patients presenting with UGIB...

Both the Blatchford and pre-endoscopic Rockall scoring systems are based on parameters that can be assessed during first

presentation. The pre-endoscopy Rockall scoring system is based on the patient's age, comorbidities, and signs of shock on

presentation. By contrast, the Blatchford scale does not consider age, but does assess urea and hemoglobin levels. The

Blatchford scale is also more focused on symptoms than the Rockall scoring system.

Page 27: UGIB CASE STUDY

Pang and colleagues assessed the two scoring systems prospectively in 1,087 patients presenting with UGIB. Endoscopic therapy was given to 297 (27.3%) of the patients. The decision to apply endoscopic treatment was made by the individual endoscopist, who was guided by an in-hospital protocol that required such treatment for all actively bleeding lesions, as well as for visible vessels and adherent clots.

Patients requiring endoscopic treatment were divided fairly equally over all the Rockall score categories. The pre-endoscopic

Rockall score was thus unable to predict the need for endoscopic treatment. By contrast, the Blatchford score was able to

make this prediction, as none of the patients with a score of 0 needed endoscopic intervention. The investigators conclude

that the Blatchford score, but not the pre-endoscopic Rockall score, is a useful predictor of the need for endoscopic

intervention. The Blatchford score can, therefore, be used to immediately discharge the subgroup of patients that present

with UGIB who are at low risk and so can return to the hospital at a later date for outpatient endoscopic treatment.3

The results of this study provide valuable confirmation of the usefulness of the Blatchford score for the identification of low-

risk patients, enabling the targeted use of resources. Pang et al.'s findings support the recommendation of the latest

international guidelines that strongly advise the use of pre-endoscopic risk assessment scores in patients with nonvariceal

UGIB. Several other reports also confirmed that patients with a Blatchford score of 0 rarely require endoscopic intervention.

The clinical impact of these important observations is, however, limited by two closely related factors. First, a minority of

cases have a Blatchford score of 0. In Pang et al.'s study, 4.6% (n = 50) of patients were given this score.3 In other studies the

proportion of patients given a Blatchford score of 0 varied between 1% and 15%.Second, the positive predictive value of a

Blatchford score >1 for the need for intervention is low. For these reasons, the next question that needs to be addressed is

whether the clinical impact of the Blatchford score can be augmented. In contrast to the pre-endoscopic Rockall score, the

probability of the need for intervention increases with increasing Blatchford scores.

In a UK study to validate the Blatchford scoring system, approximately 20% of the participants had a score of 1 or 2, and 5%

of these patients required intervention.5Similarly, Pang and colleagues found that one-fifth of patients had a score of 1 or 2,

but 16% required endoscopic treatment.3 This difference in the need for endoscopic treatment is remarkable because Pang

and colleagues' study only used endoscopic intervention as the outcome parameter, whereas the UK study also included

other interventions, such as blood transfusion, in their outcome parameter. None of the available studies provided more

detailed information regarding the endoscopic appearance of the bleeding lesion and the type of intervention provided. Such

information is needed from future studies to enable the selection of a more sizable proportion of patients with UGIB for

endoscopy on an outpatient basis. This strategy would better reflect the fact that only a minority of patients with UGIB

require endoscopic treatment.3,5

Together, these data support the use of prognostic scores for rapid assessment of patients with UGIB, as recommended by

international guidelines. Unfortunately, this strong recommendation is not routinely followed. In a nationwide survey of

6,750 patients with UGIB in more than 200 UK hospitals, pre-endoscopic risk assessment did not influence timing of

endoscopy in hospitalized patients and 42% of high-risk patients did not undergo endoscopy within 24 h, as recommended

by the international guidelines.9The results of this audit probably reflect the situation in many other countries around the

world. These results also show that studies, such as the one by Pang et al., are urgently required to assess the performance

of prognostic scales and stress the need for their use in the treatment of patients with UGIB—a condition associated with

serious comorbidity and mortality.

In conclusion, international guidelines strongly recommend the use of pre-endoscopic risk assessment scores to stratify

patients as either low-risk or high-risk, and thus determine the use of resources and timing of endoscopy. Pang and

Page 28: UGIB CASE STUDY

colleagues' findings suggest that the Blatchford score is more useful for this purpose than the pre-endoscopic Rockall score.

A low Blatchford score is adequate for the selection of patients who are unlikely to require endoscopic intervention. In some

series, these patients are identified by a score of 0, in others by a score of <2. Further studies are now required to improve

the predictive value of the Blatchford scoring system.

Competing interests statement

The author declares no competing interests.

References

1. van Leerdam, M. E. et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am. J. Gastroenterol. 98, 1494–1499 (2003)

2. Article 3. PubMed 4. ChemPort 5. Barkun, A. N. et al. International consensus recommendations on the management of patients with nonvariceal upper

gastrointestinal bleeding. Ann. Intern. Med. 152, 101–113 (2010).6. Pub Med7. Pang, S. H. et al. Comparing the Blatchford and pre-endoscopic Rockall score

SUMMARY

Originates in the GI tract from the mouth to the ligament of Treitz where the duodenum, the first part of the small intestine, ends. Bleeding from the esophagus may occur from esophageal varices, dilation of the veins in the esophagus. One of the symptoms of upper GI bleeding is vomiting of blood (hematemesis).If the blood travelsthrough the GI tract, the stool may appear tarry and black (melena) because of digested blood, though the stool can still be stained with red blood (hematochezia). About 75% of patients presenting to the emergency room with GI bleeding have an upper source. The diagnosis is easier when the patient has hematemesis. In the absence of hematemesis, 40% to 50% of patients in the emergency room with GI bleeding have an upper source. Determining whether a patient truly has an upper GI bleed versus lower gastrointestinal bleeding is difficult. Mortality is about 11% in patients admitted with an UGIB.2 It is as high as 33% in patients who develop bleeding whilst in hospital. A score of less than 3 using the Rockall system above is associated with an excellent prognosis, whereas a score of 8 or above is associated with high mortality.3 Most deaths occur in elderly patients with co-morbidity. Mortality is reported to be lower in specialist units possibly because of adherence to protocols rather than because of technical advances.2 The prognosis in liver disease relates significantly to the severity of the liver disease rather than to the magnitude of the haemorrhage

Upper gastrointestinal bleeding is commonly caused by bleeding varices (varicose veins) in the esophagus, peptic ulcers or a Mallory- Weiss tear at the esophageal gastric junction from severe retching .Otherwise, bleeding over time results in anemia, characterized by lower than normal blood hemoglobin and hematocrit with symptoms like weakness, fatigue, and fainting.

The most important step to evaluate upper GI bleeding is upper endoscopy. During this procedure, performed by a

gastroenterologist, a tube with a camera (endoscope) is passed into the mouth and down the esophagus. The

gastroenterologist can proceed to the stomach and duodenum and localize the source of the bleeding, if possible. Other

examination to determine UGIB are Vital signs, in order to determine the severity of bleeding and the timing of intervention.

Page 29: UGIB CASE STUDY

Abdominal and rectal examination, in order to determine possible causes of hemorrhage. Assessment for portal

hypertension and stigmata of chronic liver disease in order to determine if the bleeding is from a variceal source.

Laboratory findings include anemia, coagulopathy, and an elevated BUN-to-creatinine ratio.

Emergency treatment for upper GI bleeds includes aggressive replacement of volume with intravenous solutions,

and blood products if required. As patients with esophageal varices typically have coagulopathy, plasma products may have to

be administered. Vital signs are continuously monitored.Early endoscopy is recommended, both as a diagnostic and therapeutic

approach, as endoscopic treatment can be performed through the endoscope. Therapy depends on the type of lesion

identified, and can include:injection of adrenaline or other sclerotherapy, electrocautery, endoscopic clipping, or banding

of varices. Stigmata of high risk include active bleeding, oozing, visible vessels and red spots. Clots that are present on the

bleeding lesion are usually removed in order to determine the underlying pathology, and to determine the risk for rebleeding.

Pharmacotherapy includes the following: Proton pump inhibitors (PPIs), which reduce gastric acid production and accelerate

healing of certain gastric, duodenal and esophageal sources of hemorrhage. These can be administered orally or intravenously

as an infusion depending on the risk of rebleeding. Octreotide is a somatostatin analog believed to shunt blood away from the

splanchnic circulation. It has found to be a useful adjunct in management of both variceal and non-variceal upper GI

hemorrhage. It is the somatostatin analog most commonly used in North America. Terlipressin is a vasopressin analog most

commonly used in Europe for variceal upper GI hemorrhage. Antibiotics are prescribed in upper GI bleeds associated

with portal hypertension.

If Helicobacter pylori is identified as a contributant to the source of hemorrhage, then therapy with antibiotics and a PPI is

suggested.

Reaction:

Nowadays there are many technologies discovered to treat diseases like the Upper Gastrointestinal Bleeding. Before UGIB is

difficult to treat because of lack of equipments and high technology equipments and because of that the mortality of UGIB is

very high. Until they discovered endoscopy (means looking inside and typically refers to looking inside the body for medical reasons using

an endoscope an instrument used to examine the interior of a hollow organ or cavity of the body. Unlike most other medical imaging devices,

endoscopes are inserted directly into the organ) to treat UGIB. It is easier now to treat UGIB with the new way while maintaining the

medications prescribed, but still there is disadvantage with endoscopy like risk for infection due to sepsis. The mortality of

UGIB now is low unlike before.

Page 30: UGIB CASE STUDY

University of Perpetual Help College of Manila

214 V Concepcion Street Sampaloc Manila

Case Study of

Upper Gastrointestinal Bleeding

Submitted to: Submitted by: Racca, Freegie B.

Ms. Ma. Evelyn Lumio


Recommended